Heart Protein Mutation Disrupts Cell Communication Leading to Heart Failure
Scientists discover how a genetic mutation breaks communication between heart muscle and energy-producing mitochondria, causing dilated cardiomyopathy.
Summary
Researchers identified a novel genetic mechanism causing dilated cardiomyopathy (DCM), a serious heart condition. They found that a mutation in cardiac troponin T (cTnT) disrupts communication between heart muscle fibers and mitochondria, the cell's powerhouses. Using patient stem cells and mouse models, they showed this mutation weakens protein interactions, leading to excessive mitochondrial fragmentation and heart dysfunction. The discovery reveals new therapeutic targets for treating this inherited heart disease.
Detailed Summary
This groundbreaking study reveals how genetic mutations can disrupt the delicate communication between heart muscle and cellular energy systems, leading to heart failure. Dilated cardiomyopathy affects millions worldwide and often has genetic origins, but the precise mechanisms remained unclear.
Researchers studied a family with inherited heart disease and identified a novel mutation in cardiac troponin T (cTnT), a key protein in heart muscle contraction. Using patient-derived stem cells converted to heart cells, plus genetically modified mice, they traced how this single genetic change cascades into heart failure.
The mutation disrupts the normal interaction between cTnT and regulatory proteins called 14-3-3. When this connection weakens, the freed 14-3-3 proteins inappropriately activate cellular signaling pathways, ultimately causing mitochondria to fragment excessively. This mitochondrial damage severely impairs the heart's energy production and contractile function.
Importantly, the researchers demonstrated that blocking mitochondrial fragmentation with an experimental drug improved heart function in their mouse model, suggesting potential therapeutic approaches. This work provides the first clear mechanistic link between sarcomere dysfunction and mitochondrial damage in inherited cardiomyopathy, opening new avenues for treatment development targeting these cellular communication pathways.
Key Findings
- Novel cTnT mutation (p.K185E) identified as cause of familial dilated cardiomyopathy
- Mutation disrupts cTnT-14-3-3 protein interactions, releasing regulatory proteins
- Free 14-3-3 proteins activate RAS/RAF1 signaling, causing mitochondrial fragmentation
- Mitochondrial fission inhibitor improved heart function in mouse models
- Study reveals new therapeutic targets for inherited heart disease
Methodology
Study used patient-derived induced pluripotent stem cells, CRISPR gene editing, and knock-in mouse models. Researchers employed RNA sequencing, metabolite profiling, and protein interaction studies to elucidate molecular mechanisms.
Study Limitations
Study based on single family cohort and specific mutation. Mouse model findings may not fully translate to human disease complexity. Therapeutic interventions tested only in preclinical models requiring further validation.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
